ccinfoadmin

Glucometer versus analyzer: comparable results with negligible clinical risk​Alper Gümüş Cihan Coşkun Kamil Taha Uçar İbrahim Erdin Semih Tek Betül Evran Abdulkadir Çat Oğuzhan Zengi a Department of Medical Biochemistry, Health Science University, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkeyb Medical Biochemistry, Health Science University, Istanbul Gaziosmanpasa Training and Research Hospital, Istanbul, Turkeyon January 25, 2025 at 12:26 pm

by

Volume 85, Issue 1, February 2025, Page 11-19.

Circadian rhythm and the influence of light on parameters related to calcium metabolism in stroke patients admitted for rehabilitation​Shanga Hassan Qadir Helle Klingenberg Iversen Niklas Rye Jørgensen Poul Jørgen Jennum Henriette Pia Sennels Anders Sode West a Clinical Stroke Research Unit, Department of Neurology, University Hospital Rigshospitalet, Glostrup, Denmarkb Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmarkc Department of Clinical Biochemistry, University Hospital Rigshospitalet, Glostrup, Denmarkd Translational Research Centre, University Hospital Rigshospitalet, Glostrup, Denmarke Department of Clinical Neurophysiology, Danish Center for Sleep Medicine, University Hospital Rigshospitalet, Glostrup, Denmarkf Department of Clinical Biochemistry, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmarkon February 6, 2025 at 2:55 am

by

Volume 85, Issue 1, February 2025, Page 41-50.

A New CRC Blood Test Is Here. What Does It Mean for Screening?

by

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA’s approval of Shield (Guardant Health) marks a notable achievement, as individuals at average risk now have the option to receive a simple blood test for CRC screening, starting at age 45. “No one has an … Read more

Master copper regulator discovery may offer Alzheimer’s clues

by

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA editing discovery began with studies using bacteria just a decade prior. Today, CRISPR therapies are approved for several disorders, and more such treatments are … Read more

Rapid blood diagnostic test developed for amyotrophic lateral sclerosis

by

A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects neurons in the brain and spinal cord. ALS leads to gradual paralysis, ultimately resulting in the inability to walk, speak, or, in later stages, move. Currently, diagnosis is based on a thorough clinical examination, but … Read more

What makes urine yellow? Scientists discover the enzyme responsible

by

Researchers at the University of Maryland and National Institutes of Health have identified the microbial enzyme responsible for giving urine its yellow hue, according to a new study published in the journal Nature Microbiology. The discovery of this enzyme, called bilirubin reductase, paves the way for further research into the gut microbiome’s role in ailments like jaundice … Read more

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri error code: 520